Literature DB >> 27026499

A systematic review of preoperative determinants of patient-reported pain and physical function up to 2 years following primary unilateral total hip arthroplasty.

E Lungu1, S Maftoon2, P-A Vendittoli3, F Desmeules4.   

Abstract

UNLABELLED: Although generally considered successful, total hip arthroplasty (THA) can yield suboptimal results in terms of pain and function in up to one forth of patients suffering from hip osteoarthritis (OA). A thorough understanding of the determinants of patient-reported pain and function following THA can help plan interventions directed at improving surgical results. Previously published systematic reviews do not permit to confidently identify the determinants of THA outcomes because of unsatisfactory methodological designs. Therefore, we aimed to answer: (1) which preoperative factors are most consistently associated with postoperative patient-reported pain and function up to 2 years following primary unilateral THA for hip OA. Medline, Pubmed, Embase and CINAHL were screened from their respective inception dates until April 2015 using a combination of keywords and MESH terms. Criteria for inclusion were: (1) participants with primary unilateral THA for hip OA followed for at least 3 months with a maximal follow-up of 2 years; (2) validated disease-specific patient-reported outcome measures assessing pain and/or disability; (3) identification of determinants obtained via multivariate analyses. Methodological quality was assessed using a modified version of the methodology checklist for prognostic studies. Twenty-two manuscripts were included. Mean score of the methodological quality was 81.0±10.3% (66.7% to 100%). Among socioeconomic determinants, a lower educational level was significantly related to worse pain and function (3 out of 3 studies evaluating the relationship). Clinical determinants of poor outcomes included preoperative levels of pain and physical function (9 out of 12 studies), higher body mass index (6 out of 10 studies), presence/greater level of comorbidities (7 out of 8), worse general health (4 out of 4 studies) and lower radiographic OA severity (3 out of 4 studies). Study heterogeneity limited the pooled assessment of the strength of associations between the preoperative variables and THA outcomes. Studies with moderate-to-high methodological quality allowed to identify 6 preoperative variables consistently associated with medium term pain and function following THA. This knowledge may assist the management of patients at risk of poor results. Further research is required to clarify the force of associations between determinants and THA outcomes. LEVEL OF EVIDENCE: Level II. Systematic review of cohort studies.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Determinants; Disability; Hip osteoarthritis; Pain; Total hip arthroplasty

Mesh:

Year:  2016        PMID: 27026499     DOI: 10.1016/j.otsr.2015.12.025

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  11 in total

1.  Early Clinically Relevant Improvement in Quality of Life and Clinical Outcomes 1 Year Postsurgery in Patients with Knee and Hip Joint Arthroplasties.

Authors:  Audrey Neuprez; Arnaud H Neuprez; Jean-François Kaux; William Kurth; Christophe Daniel; Thierry Thirion; Jean-Pierre Huskin; Philippe Gillet; Olivier Bruyère; Jean-Yves Reginster
Journal:  Cartilage       Date:  2017-12-21       Impact factor: 4.634

2.  Patient-reported outcome of 95% of young patients improves after primary total hip arthroplasty: identification of 3 recovery trajectories in 3,207 patients younger than 55 years from the Dutch Arthroplasty Register.

Authors:  Martijn F L Kuijpers; Liza N Van Steenbergen; B Willem Schreurs; Gerjon Hannink
Journal:  Acta Orthop       Date:  2022-06-20       Impact factor: 3.925

3.  Recovery and the use of postoperative physical therapy after total hip or knee replacement.

Authors:  L Groot; D A J M Latijnhouwers; M Reijman; S H M Verdegaal; T P M Vliet Vlieland; M G J Gademan
Journal:  BMC Musculoskelet Disord       Date:  2022-07-13       Impact factor: 2.562

4.  Comparison of two different stems for total hip arthroplasty.

Authors:  Pedram Yavari; Bahareh Baghchi; Mehdi Tavassoli; Pouya Moshkdar; Sepehr Eslami; Amirhossein Sadeghian; Ghasem Mohammadsharifi
Journal:  Int J Burns Trauma       Date:  2021-06-15

Review 5.  [Decision for total hip arthroplasty-the surgeons' view].

Authors:  Anne Postler; Cornelia Lützner; Toni Lange; Jochen Schmitt; Jörg Lützner; Klaus-Peter Günther
Journal:  Orthopade       Date:  2021-03-05       Impact factor: 1.087

6.  Preoperative medications is one of the factor affecting patient-reported outcomes after total hip arthroplasty.

Authors:  Takanori Miura; Hiroaki Kijima; Natsuo Konishi; Hitoshi Kubota; Shin Yamada; Hiroshi Tazawa; Takayuki Tani; Norio Suzuki; Keiji Kamo; Masashi Fujii; Ken Sasaki; Tetsuya Kawano; Yosuke Iwamoto; Itsuki Nagahata; Naohisa Miyakoshi; Yoichi Shimada
Journal:  J Orthop       Date:  2020-12-30

7.  Is the Preoperative Use of Antidepressants and Benzodiazepines Associated with Opioid and Other Analgesic Use After Hip and Knee Arthroplasty?

Authors:  Tuomas J Rajamäki; Teemu Moilanen; Pia A Puolakka; Aki Hietaharju; Esa Jämsen
Journal:  Clin Orthop Relat Res       Date:  2021-10-01       Impact factor: 4.755

Review 8.  Total Hip Replacement for Osteoarthritis-Evidence-Based and Patient-Oriented Indications.

Authors:  Klaus-Peter Günther; Stefanie Deckert; Cornelia Lützner; Toni Lange; Jochen Schmitt; Anne Postler
Journal:  Dtsch Arztebl Int       Date:  2021-10-29       Impact factor: 8.251

9.  The first 6 weeks of recovery after primary total hip arthroplasty with fast track.

Authors:  Lisette C M Klapwijk; Nina M C Mathijssen; Jeroen C Van Egmond; Bianca M Verbeek; Stephan B W Vehmeijer
Journal:  Acta Orthop       Date:  2017-01-12       Impact factor: 3.717

10.  Predictors of the use of analgesic drugs 1 year after joint replacement: a single-center analysis of 13,000 hip and knee replacements.

Authors:  Tuomas Jaakko Rajamäki; Pia A Puolakka; Aki Hietaharju; Teemu Moilanen; Esa Jämsen
Journal:  Arthritis Res Ther       Date:  2020-04-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.